1 completed, 1 recruiting, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Olaparib 150 MG: new trials by email Literature Review of Olaparib 150 MG trials Research Report on Olaparib 150 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Olaparib 150 MG - Ovarian Cancer | Phase 1 | Recruiting | Boryung Pharmaceutical Co., Ltd | 24 | 2025-06-17 | 2025-07-16 |
| Olaparib in PALB2 Advanced Pancreatic Cancer Olaparib 150 MG - Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer | Phase 2 | Unknown | Azienda Ospedaliero-Universitaria di Modena | 16 | 2023-08-01 | 2024-05-06 |
| Olaparib in Recurrent IDH-mutant Glioma Olaparib 150 MG - Recurrent IDH, Mutant High Grade Glioma | Phase 2 | Completed | Hospices Civils de Lyon | 35 | 2019-03-20 | 2025-09-12 |
Glioma (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Recurrence (1)
Azienda Ospedaliero-Universitaria di Modena (1) · Boryung Pharmaceutical Co., Ltd (1) · Hospices Civils de Lyon (1)
France (1) · Italy (1) · South Korea (1)
2018 (1)